(+)-p-([F-18]fluorobenzyl)spirotrozamicol{(+)-[F-18]spiro-FBT}: Synthesis and biological evaluation of a high-affinity ligand for the vesicular acetylcholine transporter (VAChT)

Citation
Smn. Efange et al., (+)-p-([F-18]fluorobenzyl)spirotrozamicol{(+)-[F-18]spiro-FBT}: Synthesis and biological evaluation of a high-affinity ligand for the vesicular acetylcholine transporter (VAChT), NUCL MED BI, 26(2), 1999, pp. 189-192
Citations number
22
Categorie Soggetti
Medical Research Diagnosis & Treatment
Journal title
NUCLEAR MEDICINE AND BIOLOGY
ISSN journal
09698051 → ACNP
Volume
26
Issue
2
Year of publication
1999
Pages
189 - 192
Database
ISI
SICI code
0969-8051(199902)26:2<189:(SA>2.0.ZU;2-P
Abstract
(+)-1'-[4-Hydroxy-1-(4-fluorobenzyl)piperidin-3-yl]spiro[1H-indene-1,4'-pip eridine] {(+)- Spiro-FBT}, a high-affinity vesicular acetylcholine transpor ter ligand, was labeled with fluorine-18, and evaluated in the rat and monk ey. In the rat brain, (+)-[F-18]Spiro-FBT accumulated preferentially in the striatum, hippocampus, and cortex, brains regions containing high-to-moder ate densities of cholinergic terminals. However, due to rapid metabolism, n o preferential accumulation of the radiotracer was observed in correspondin g regions of the monkey brain. Consequently, rapid metabolism renders (+)-[ F-18]Spiro-FBT unsuitable for studying cholinergic function with positron e mission tomography. NUCL MED BIOL 26;2: 189-192, 1999. (C) 1999 Elsevier Sc ience Inc. All rights reserved.